FA
PSTX
Forefront Analytics’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-27,855
| Closed | -$79.7K | – | 71 |
|
|
2024
Q3 | $79.7K | Sell |
27,855
-1,962
| -7% | -$5.61K | 0.04% | 65 |
|
|
2024
Q2 | $87.1K | Buy |
29,817
+3,037
| +11% | +$8.87K | 0.04% | 64 |
|
|
2024
Q1 | $85.4K | Buy |
26,780
+1,311
| +5% | +$4.18K | 0.04% | 64 |
|
|
2023
Q4 | $85.6K | Buy |
25,469
+500
| +2% | +$1.68K | 0.04% | 61 |
|
|
2023
Q3 | $59.4K | Sell |
24,969
-1,650
| -6% | -$3.93K | 0.03% | 63 |
|
|
2023
Q2 | $46.9K | Buy |
26,619
+11,579
| +77% | +$20.4K | 0.03% | 64 |
|
|
2023
Q1 | $46.3K | Sell |
15,040
-230
| -2% | -$708 | 0.02% | 75 |
|
|
2022
Q4 | $80.9K | Sell |
15,270
-380
| -2% | -$2.01K | 0.04% | 61 |
|
|
2022
Q3 | $59K | Sell |
15,650
-7,720
| -33% | -$29.1K | 0.03% | 61 |
|
|
2022
Q2 | $61K | Sell |
23,370
-3,400
| -13% | -$8.88K | 0.03% | 59 |
|
|
2022
Q1 | $121K | Buy |
26,770
+16,150
| +152% | +$73K | 0.04% | 58 |
|
|
2021
Q4 | $72K | Buy |
10,620
+275
| +3% | +$1.86K | 0.02% | 59 |
|
|
2021
Q3 | $72K | Buy |
+10,345
| New | +$72K | 0.03% | 62 |
|